Literature DB >> 19833271

Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis.

Muhittin Tasdogan1, Dilek Memis, Necdet Sut, Mahmut Yuksel.   

Abstract

STUDY
OBJECTIVE: To compare the effects of an intravenous infusion of propofol and the alpha-2 adrenoceptor, dexmedetomidine, on inflammatory responses and intraabdominal pressure (IAP) in severe sepsis after abdominal surgery, specifically, serum cytokine levels (interleukin [IL]-1, IL-6, and tumor necrosis factor [TNF]-alpha) and IAP.
DESIGN: Prospective, single-center study.
SETTING: University hospital. PATIENTS: 40 adult ICU patients who had undergone ileus surgery and who were expected to require postoperative sedation and ventilation.
INTERVENTIONS: Patients received either a loading dose infusion of propofol (Group P; n = 20) one mg/kg over 15 minutes followed by a maintenance dose of one to three mg/kg/hr (n = 20, Group P) or a loading dose of dexmedetomidine of one microg/kg over 10 minutes followed by a maintenance dose of 0.2-2.5 microg/kg/h (n = 20, Group D) at the 24th hour. MEASUREMENTS: Biochemical and hemodynamic parameters, cytokine levels, and IAP were recorded before the start of the study and at the 24th and 48th hours. MAIN
RESULTS: TNF-alpha levels were significantly lower at the 24th hour (14.66 +/- 4.40 pg/mL vs. 21.21 +/- 11.37 pg/mL, respectively) and at the 48th hour (21.25 +/- 15.85 pg/mL vs. 46.55 +/- 35.99 pg/mL, respectively) in Group D. IL-1 levels were significantly lower at the 24th hour (5.03 +/- 0.15 pg/mL vs. 6.23 +/- 2.09 pg/mL, respectively) and the 48th hour (5.01 +/- 0.37 pg/mL vs. 6.42 +/- 2.76 pg/mL, respectively) in Group D. IL-6 levels were significantly lower at the 24th hour (253.1 +/- 303.6 pg/mL and 511.3 +/- 374.8 pg/mL, respectively) and at the 48th hour (343.5 +/- 393.4 pg/mL and 503.7 +/- 306.4 pg/mL, respectively) in Group D. Intraabdominal pressure also was significantly lower at the 24th hour (12.35 +/- 5.84 mmHg vs. 18.1 +/- 2.84 mmHg, respectively) and the 48th hour (13.9 +/- 6.15 mmHg vs. 18.7 +/- 3.46 mmHg, respectively) in Group D.
CONCLUSION: Dexmedetomidine infusion decreases TNF-a, IL-1, and IL-6 levels and IAP more than a propofol infusion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19833271     DOI: 10.1016/j.jclinane.2008.10.010

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  55 in total

Review 1.  Hypothesis: Fever control, a niche for alpha-2 agonists in the setting of septic shock and severe acute respiratory distress syndrome?

Authors:  F Petitjeans; S Leroy; C Pichot; A Geloen; M Ghignone; L Quintin
Journal:  Temperature (Austin)       Date:  2018-05-22

Review 2.  Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients.

Authors:  Ken Chen; Zhijun Lu; Yi Chun Xin; Yong Cai; Yi Chen; Shu Ming Pan
Journal:  Cochrane Database Syst Rev       Date:  2015-01-06

3.  Circulatory effects of dexmedetomidine in early sepsis: a randomised controlled experimental study.

Authors:  Zoi Aidoni; Chryssa Pourzitaki; Eleni Stamoula; Katerina Kotzampassi; Georgia Tsaousi; George Kazakos; Christophoros N Foroulis; Charisios Skourtis; Dimitrios G Vasilakos; Vassilios Grosomanidis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-17       Impact factor: 3.000

Review 4.  Sedation for critically ill or injured adults in the intensive care unit: a shifting paradigm.

Authors:  Derek J Roberts; Babar Haroon; Richard I Hall
Journal:  Drugs       Date:  2012-10-01       Impact factor: 9.546

5.  Sedation and analgesia in mechanically ventilated preterm neonates: continue standard of care or experiment?

Authors:  Christopher McPherson
Journal:  J Pediatr Pharmacol Ther       Date:  2012-10

Review 6.  Acute abdominal compartment syndrome: current diagnostic and therapeutic options.

Authors:  A Hecker; B Hecker; M Hecker; J G Riedel; M A Weigand; W Padberg
Journal:  Langenbecks Arch Surg       Date:  2015-10-30       Impact factor: 3.445

7.  Effects of intra-abdominal pressure on liver function assessed with the LiMON in critically ill patients.

Authors:  Mehmet Turan Inal; Dilek Memis; Y Atakan Sezer; Meltem Atalay; Abdullah Karakoc; Necdet Sut
Journal:  Can J Surg       Date:  2011-06       Impact factor: 2.089

8.  Dexmedetomidine versus standard therapy with fentanyl for sedation in mechanically ventilated premature neonates.

Authors:  Keliana O'Mara; Peter Gal; John Wimmer; J Laurence Ransom; Rita Q Carlos; Mary Ann V T Dimaguila; Christie C Davanzo; McCrae Smith
Journal:  J Pediatr Pharmacol Ther       Date:  2012-07

9.  Activation of α2 adrenoceptor attenuates lipopolysaccharide-induced hepatic injury.

Authors:  Jing-Hui Chen; Gao-Feng Yu; Shang-Yi Jin; Wen-Hua Zhang; Dong-Xu Lei; Shao-Li Zhou; Xing-Rong Song
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial.

Authors:  Pratik P Pandharipande; Robert D Sanders; Timothy D Girard; Stuart McGrane; Jennifer L Thompson; Ayumi K Shintani; Daniel L Herr; Mervyn Maze; E Wesley Ely
Journal:  Crit Care       Date:  2010-03-16       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.